Haleon PLC Sponsored ADR (NYSE:HLN) Receives Consensus Rating of “Moderate Buy” from Analysts

Haleon PLC Sponsored ADR (NYSE:HLN) has received a consensus rating of “Moderate Buy” from the nine brokerages that are covering the firm, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating, three have assigned a buy rating and two have assigned a strong buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $12.3250.

Several equities research analysts have recently issued reports on HLN shares. BNP Paribas upgraded Haleon to a “strong-buy” rating in a report on Tuesday, May 27th. Barclays reaffirmed an “overweight” rating on shares of Haleon in a research report on Tuesday, May 6th. Wall Street Zen lowered Haleon from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. BNP Paribas Exane raised Haleon from a “neutral” rating to an “outperform” rating and set a $13.40 target price on the stock in a research report on Tuesday, May 27th. Finally, Morgan Stanley raised Haleon from an “equal weight” rating to an “overweight” rating and set a $11.25 target price on the stock in a research report on Friday, May 9th.

Haleon Trading Down 0.1%

Shares of NYSE HLN opened at $9.8050 on Friday. The stock has a fifty day simple moving average of $9.93 and a 200-day simple moving average of $10.21. The stock has a market capitalization of $44.01 billion, a PE ratio of 25.14, a PEG ratio of 2.90 and a beta of 0.23. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. Haleon has a twelve month low of $8.86 and a twelve month high of $11.42.

Haleon Increases Dividend

The business also recently disclosed a semi-annual dividend, which will be paid on Thursday, September 18th. Shareholders of record on Friday, August 15th will be given a $0.0555 dividend. This represents a yield of 190.0%. This is a boost from Haleon’s previous semi-annual dividend of $0.05. The ex-dividend date of this dividend is Friday, August 15th. Haleon’s dividend payout ratio is 28.21%.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in HLN. Hanson & Doremus Investment Management grew its stake in shares of Haleon by 234.1% during the second quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock valued at $25,000 after acquiring an additional 1,662 shares in the last quarter. Bartlett & CO. Wealth Management LLC grew its stake in shares of Haleon by 135.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock valued at $27,000 after acquiring an additional 1,491 shares in the last quarter. Banque Transatlantique SA acquired a new stake in shares of Haleon during the first quarter valued at about $27,000. Golden State Wealth Management LLC grew its stake in shares of Haleon by 107.6% during the second quarter. Golden State Wealth Management LLC now owns 2,721 shares of the company’s stock valued at $28,000 after acquiring an additional 1,410 shares in the last quarter. Finally, Opal Wealth Advisors LLC acquired a new stake in shares of Haleon during the first quarter valued at about $29,000. 6.67% of the stock is owned by hedge funds and other institutional investors.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.